Nalaganje...
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the treatment of invasive fungal infections. Here we de...
Shranjeno v:
| izdano v: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7069493/ https://ncbi.nlm.nih.gov/pubmed/31904836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz529 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|